Evidence map›Paper›PMID 40400686›Full record

ArticleFrontiers in microbiology2025

Epidemiology and resistance mechanisms of tigecycline- and carbapenem-resistant

Lixin Yan, Tingting Ma, Wen Wang, Zhen Cai, Hong Du, Zhongju Chen, Renru Han, Yan Guo, Gang Li, Wei Jia and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Transcriptomic correlates of ceftazidime-avibactam collateral sensitivity in tigecycline-resistant NDM-producing enterobacter cloacae complex.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lixin Yan *The First Clinical Medical College of Ningxia Medical University, Yinchuan, China.
Tingting Ma *The First Clinical Medical College of Ningxia Medical University, Yinchuan, China.
Wen WangLaboratory Medical Center, General Hospital of Ningxia Medical University, Yinchuan, China.
Zhen CaiDepartment of Clinical Laboratory, Aviation General Hospital, Beijing, China.
Hong DuDepartment of Clinical Laboratory, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Zhongju ChenDepartment of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Renru HanInstitute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Yan GuoInstitute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Gang LiThe First Clinical Medical College of Ningxia Medical University, Yinchuan, China.
Wei JiaThe First Clinical Medical College of Ningxia Medical University, Yinchuan, China.
Jia TaoThe First Clinical Medical College of Ningxia Medical University, Yinchuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To elucidate the molecular epidemiology of tigecycline and carbapenem-resistant Methods: We gathered 31 unduplicated strains of tigecycline-resistant Results: All 31 tigecycline-resistant Conclusion: The overall carriage rate of the

Indexed as

CREgenemic analysistet(A)tigecycline resistancetmexCD2-toprJ2

Identifiers

PMID40400686
PMCPMC12092438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.